Status:
UNKNOWN
The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B Patients
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Hepatitis B, Chronic
Adherence, Medication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the effect of the education given to patients with CHB who use oral antiviral drugs on oral antiviral drug use on drug compliance and quality of life.
Eligibility Criteria
Inclusion
- Being diagnosed with CHB for at least 6 months,
- To be over 18 years old,
- Using oral antiviral treatment for at least three months,
- To be a literate person,
- No malignancy other than hepatocellular carcinoma,
- Not having vision and hearing problems,
- Not having cognitive or psychiatric problems,
- Patients/patient relatives who can use smartphones (In order to invite the patients to the 3rd and 6th month controls and to inform and remind the experimental group about the training time, they / their relatives should have and can use a mobile phone)
- Volunteer to participate in the study.
Exclusion
- •Continuing to use alcohol after the first evaluation,
- Not willing to participate in the study,
- Patients with a psychiatric diagnosis,
- Patients who do not meet the sample inclusion criteria.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05286216
Start Date
April 15 2022
End Date
December 25 2022
Last Update
March 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.